Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Fukuda

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Clinical Pharmacokinetics|September 18, 2017
Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell TransplantationKana Mizuno, Min Dong, Tsuyoshi Fukuda, et al.
Frontiers in Pediatrics|March 14, 2022
Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab DosingStefanie W Benoit, Tsuyoshi Fukuda, Katherine VandenHeuvel, et al.
Journal of Clinical Pharmacology|April 27, 2010
Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipientsTsuyoshi Fukuda, Jens Goebel, Håvard Thøgersen, et al.
Therapeutic Drug Monitoring|May 20, 2020
Model-Informed Bayesian Estimation Improves the Prediction of Morphine Exposure in Neonates and InfantsJoshua C Euteneuer, Tomoyuki Mizuno, Tsuyoshi Fukuda, et al.
Pharmacogenomics|July 18, 2013
OCT1 genetic variants influence the pharmacokinetics of morphine in childrenTsuyoshi Fukuda, Vidya Chidambaran, Tomoyuki Mizuno, et al.
Transplantation|April 12, 2012
Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantationDavid K Hooper, Tsuyoshi Fukuda, Rhonda Gardiner, et al.
Journal of Opioid Management|September 4, 2012
Morphine clearance in children: does race or genetics matter?Senthilkumar Sadhasivam, Elke H J Krekels, Vidya Chidambaran, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 20, 2007
Determination of single nucleotide polymorphisms in N-acetyltransferase2 gene using an electrochemical DNA chip and an automated DNA detection systemNaoko Nakamura, Keiko Ito, Sadato Hongo, et al.
Journal of Clinical Psychopharmacology|September 17, 2008
The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipranMasataka Wakeno, Masaki Kato, Gaku Okugawa, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2016
Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysisKevin J Downes, Min Dong, Tsuyoshi Fukuda, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Clinical Pharmacokinetics|September 18, 2017
Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell TransplantationKana Mizuno, Min Dong, Tsuyoshi Fukuda, et al.
Frontiers in Pediatrics|March 14, 2022
Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab DosingStefanie W Benoit, Tsuyoshi Fukuda, Katherine VandenHeuvel, et al.
Journal of Clinical Pharmacology|April 27, 2010
Inosine monophosphate dehydrogenase (IMPDH) activity as a pharmacodynamic biomarker of mycophenolic acid effects in pediatric kidney transplant recipientsTsuyoshi Fukuda, Jens Goebel, Håvard Thøgersen, et al.
Therapeutic Drug Monitoring|May 20, 2020
Model-Informed Bayesian Estimation Improves the Prediction of Morphine Exposure in Neonates and InfantsJoshua C Euteneuer, Tomoyuki Mizuno, Tsuyoshi Fukuda, et al.
Pharmacogenomics|July 18, 2013
OCT1 genetic variants influence the pharmacokinetics of morphine in childrenTsuyoshi Fukuda, Vidya Chidambaran, Tomoyuki Mizuno, et al.
Transplantation|April 12, 2012
Risk of tacrolimus toxicity in CYP3A5 nonexpressors treated with intravenous nicardipine after kidney transplantationDavid K Hooper, Tsuyoshi Fukuda, Rhonda Gardiner, et al.
Journal of Opioid Management|September 4, 2012
Morphine clearance in children: does race or genetics matter?Senthilkumar Sadhasivam, Elke H J Krekels, Vidya Chidambaran, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|April 20, 2007
Determination of single nucleotide polymorphisms in N-acetyltransferase2 gene using an electrochemical DNA chip and an automated DNA detection systemNaoko Nakamura, Keiko Ito, Sadato Hongo, et al.
Journal of Clinical Psychopharmacology|September 17, 2008
The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipranMasataka Wakeno, Masaki Kato, Gaku Okugawa, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2016
Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysisKevin J Downes, Min Dong, Tsuyoshi Fukuda, et al.
Pageof 12